We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
(-2.8%)
Cap. Flow
-$952M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 2 |
Prologis
PLD
|
+$150M |
| 3 |
Chevron
CVX
|
+$109M |
| 4 |
Qualcomm
QCOM
|
+$101M |
| 5 |
Paycom
PAYC
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$230M |
| 2 |
Kimberly-Clark
KMB
|
+$160M |
| 3 |
Stanley Black & Decker
SWK
|
+$130M |
| 4 |
Paychex
PAYX
|
+$113M |
| 5 |
Dominion Energy
D
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Healthcare | 17.11% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HTB
1101
HomeTrust Bancshares
HTB
$773M
| $1.04M | ﹤0.01% |
34,501
| – | – |
|
1102
Antero Resources
AR
$11B
| $1.03M | ﹤0.01% |
31,637
-698
| -2% | -$22.8K |
|
1103
CleanSpark
CLSK
$3.42B
| $1.03M | ﹤0.01% |
64,410
+19,023
| +42% | +$320K |
|
1104
Jones Lang LaSalle
JLL
$15.6B
| $1.02M | ﹤0.01% |
4,975
-124
| -2% | -$24.1K |
|
1105
Dow Inc
DOW
$21.2B
| $1.02M | ﹤0.01% |
19,240
-1,259
| -6% | -$71.9K |
|
1106
Essential Utilities
WTRG
$11.7B
| $1.02M | ﹤0.01% |
27,241
-1,335
| -5% | -$49.5K |
|
1107
The Ensign Group
ENSG
$10.2B
| $1.01M | ﹤0.01% |
8,173
-3
| -0% | -$358 |
|
1108
ASE Group
ASX
$104B
| $1.01M | ﹤0.01% |
88,498
+23,403
| +36% | +$254K |
|
1109
SITE Centers
SITC
$152M
| $1.01M | ﹤0.01% |
89,147
-6,474
| -7% | -$71.2K |
|
1110
Chemed
CHE
$6.61B
| $1.01M | ﹤0.01% |
1,858
+236
| +15% | +$135K |
|
1111
Digital Turbine
APPS
$1.37B
| $1.01M | ﹤0.01% |
607,269
-240
| -0% | -$465 |
|
1112
Teekay Tankers
TNK
$3.53B
| $994K | ﹤0.01% |
14,441
+3
| +0% | +$195 |
|
1113
Expeditors International
EXPD
$24.5B
| $988K | ﹤0.01% |
7,918
-1,540
| -16% | -$183K |
|
1114
Landstar System
LSTR
$5.78B
| $987K | ﹤0.01% |
5,352
-297
| -5% | -$53.6K |
|
1115
CSX Corp
CSX
$88.2B
| $976K | ﹤0.01% |
29,178
-4,155
| -12% | -$141K |
|
1116
Welltower
WELL
$167B
| $973K | ﹤0.01% |
9,337
+1,470
| +19% | +$144K |
|
1117
F5
FFIV
$24.8B
| $971K | ﹤0.01% |
5,635
+375
| +7% | +$65.6K |
|
|
ODP
1118
DELISTED
ODP
ODP
| $968K | ﹤0.01% |
24,660
-1,922
| -7% | -$85.5K |
|
1119
RTX Corp
RTX
$261B
| $965K | ﹤0.01% |
9,613
+2,552
| +36% | +$264K |
|
|
WBS
1120
DELISTED
Webster Financial
WBS
| $962K | ﹤0.01% |
22,059
+1,830
| +9% | +$81.5K |
|
1121
Crown Holdings
CCK
$12.1B
| $961K | ﹤0.01% |
12,920
-736
| -5% | -$59.4K |
|
1122
Sun Communities
SUI
$14.1B
| $959K | ﹤0.01% |
7,971
-1,635
| -17% | -$194K |
|
1123
Crocs
CROX
$5.95B
| $958K | ﹤0.01% |
6,566
-2,153
| -25% | -$302K |
|
1124
Euronet Worldwide
EEFT
$2.57B
| $956K | ﹤0.01% |
9,241
+1,635
| +21% | +$179K |
|
1125
Kyndryl
KD
$2.85B
| $954K | ﹤0.01% |
36,271
+1,328
| +4% | +$31.8K |
|
Similar funds
Federated Hermes's Q2 2024 Portfolio in Review
As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
- Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
- Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
- Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
- Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
- Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
- Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.
Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.